• bitcoinBitcoin(BTC)$77,836.000.80%
  • ethereumEthereum(ETH)$2,271.401.35%
  • tetherTether(USDT)$1.000.03%
  • binancecoinBNB(BNB)$705.390.30%
  • rippleXRP(XRP)$1.260.68%
  • usd-coinUSDC(USDC)$1.000.02%
  • solanaSolana(SOL)$95.76-0.14%
  • tronTRON(TRX)$0.310554-4.22%
  • Figure HelocFigure Heloc(FIGR_HELOC)$1.063.50%
  • zcashZcash(ZEC)$1,251.45-0.82%
  • HyperliquidHyperliquid(HYPE)$88.15-0.11%
  • dogecoinDogecoin(DOGE)$0.0759350.76%
  • moneroMonero(XMR)$605.512.02%
  • USDSUSDS(USDS)$1.000.02%
  • chainlinkChainlink(LINK)$11.692.46%
  • whitebitWhiteBIT Coin(WBT)$74.790.87%
  • leo-tokenLEO Token(LEO)$9.40-0.57%
  • cardanoCardano(ADA)$0.1938640.36%
  • stellarStellar(XLM)$0.1692860.27%
  • nearNEAR Protocol(NEAR)$4.401.20%
  • bitcoin-cashBitcoin Cash(BCH)$286.28-1.00%
  • daiDai(DAI)$1.000.01%
  • uniswapUniswap(UNI)$7.284.45%
  • Ethena USDeEthena USDe(USDE)$1.000.01%
  • RainRain(RAIN)$0.006164-1.94%
  • litecoinLitecoin(LTC)$56.261.96%
  • avalanche-2Avalanche(AVAX)$8.985.41%
  • CantonCanton(CC)$0.0978452.05%
  • USD1USD1(USD1)$1.000.02%
  • suiSui(SUI)$0.911.23%
  • the-open-networkGram (prev. Toncoin)(GRAM)$1.222.50%
  • hedera-hashgraphHedera(HBAR)$0.0722501.11%
  • tether-goldTether Gold(XAUT)$3,867.52-0.24%
  • quant-networkQuant(QNT)$200.763.08%
  • Global DollarGlobal Dollar(USDG)$1.000.01%
  • paypal-usdPayPal USD(PYUSD)$1.00-0.01%
  • BittensorBittensor(TAO)$238.230.97%
  • shiba-inuShiba Inu(SHIB)$0.000005-0.97%
  • crypto-com-chainCronos(CRO)$0.051336-0.21%
  • EthenaEthena(ENA)$0.190020-1.26%
  • Ripple USDRipple USD(RLUSD)$1.000.05%
  • Ondo US Dollar YieldOndo US Dollar Yield(USDY)$1.150.16%
  • Circle USYCCircle USYC(USYC)$1.140.00%
  • okbOKB(OKB)$110.830.00%
  • aaveAave(AAVE)$140.166.84%
  • pepePepe(PEPE)$0.0000051.26%
  • MemeCoreMemeCore(M)$0.91-4.62%
  • BlackRock USD Institutional Digital Liquidity FundBlackRock USD Institutional Digital Liquidity Fund(BUIDL)$1.000.00%
  • OndoOndo(ONDO)$0.4145450.42%
  • Pump.funPump.fun(PUMP)$0.0042554.26%
TradePoint.io
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop
No Result
View All Result
TradePoint.io
No Result
View All Result

Ozempic, Wegovy and other weight loss drugs present holiday challenges

December 23, 2023
in Business
Reading Time: 3 mins read
A A
Ozempic, Wegovy and other weight loss drugs present holiday challenges
ShareShareShareShareShare

Celebrating the winter holidays for many means buying presents, arranging travel and planning hefty menus for meals with loved ones.

YOU MAY ALSO LIKE

Trump’s tariff craze has derailed the GOP’s hopes to maintain their authority after the 2026 midterms

West Coast favorite ice cream chain opens new Bay Area store

However, this year those preparations may include skipping medications popularly used to facilitate weight loss. 

Reasons ranging from wanting to consume more holiday food without post-meal discomfort to aiming to save money have prompted some to look to hold off on doses in the lead-up to the festivities, according to Good Morning America and other media reports. 

Still, individuals contemplating skipping their weight loss drugs need to be careful when resuming them afterwards, an expert told FOX Business.

Common types of drugs used for weight loss include Ozempic, Wegovy and Mounjaro.

The last contains tirzepatide, while the other two are semaglutide. 

Endobariatric physician and True You Weight Loss Associate Research Director Dr. Dan Maselli told FOX Business that such reasons are “totally understandable.”

Some of his patients have wanted to interrupt their dosage schedule to avoid receiving stigma-driven judgment from loved ones who didn’t know they were taking such medication, he added.

Individuals are not “going to harm themselves in the immediate future by stopping the medication” they use for weight loss, Maselli said.

Celebrating the winter holidays for many means buying presents, arranging travel and planning hefty menus for meals with loved ones. REUTERS

While skipping may lead to feelings of hunger, drugs like Ozempic and Mounjaro do not bring on a withdrawal phenomenon, he noted.

It is the resumption of the medication where people need to be careful, according to Maselli.

“These medications are really meant to be taken long-term and consistently, and one of the issues that can arise if we miss a dose, or really if we miss two to three doses, is that our body can lose how well acclimated it has become to those medications, in particular to the gastrointestinal side effects of those medications,” Maselli said.

However, this year those preparations may include skipping medications popularly used to facilitate weight loss. REUTERS

“It may be unwise and, in extreme circumstances, unsafe to start the medication back at the dose you were at.”

When using Ozempic, Mounjaro and other similar drugs for weight loss, doctors and patients have to start at a low dosage and slowly increase it over time, he explained.

That process can take 20 weeks.

Reasons ranging from wanting to consume more holiday food without post-meal discomfort to aiming to save money have prompted some to look to hold off on doses in the lead-up to the festivities. REUTERS

“So if you were at that maximum dose – or even above like the first two doses of this medication – and you stop this medication for two or three weeks, and then you try to start back on that same dose, you can make yourself really uncomfortable,” he said.

Nausea, vomiting, diarrhea, constipation, cramping and heartburn are among the symptoms a person could experience.

Maselli said that people who have missed or skipped doses should get in touch with their prescribing doctor instead of just starting back up again, because their doctor may need to lower their dose.

In some cases, they could need to start from square one, depending on how long it has been.

People deciding to temporarily stop taking the drugs during the holidays comes after more and more people have looked to Ozempic, Wegovy and Mounjaro for weight-loss help. 

Common types of drugs used for weight loss include Ozempic, Wegovy and Mounjaro. REUTERS

Novo Nordisk, which produces Ozempic and Wegovy, has seen quite a boost amid the phenomenon, with its stock price having climbed nearly 51% since the start of 2023.

Shares of the company behind Mounjaro, Eli Lilly, have gone up over 56%. 

The S&P 500, meanwhile, has posted a nearly 25% increase this year.

Credit: Source link

ShareTweetSendSharePin

Related Posts

Trump’s tariff craze has derailed the GOP’s hopes to maintain their authority after the 2026 midterms
Business

Trump’s tariff craze has derailed the GOP’s hopes to maintain their authority after the 2026 midterms

November 1, 2026
West Coast favorite ice cream chain opens new Bay Area store
Business

West Coast favorite ice cream chain opens new Bay Area store

November 1, 2026
Ray-Ban heir recounts wild pregnancy mystery with ex Jessica Serfaty: ‘I’m pregnant — It can be you or him’
Business

Ray-Ban heir recounts wild pregnancy mystery with ex Jessica Serfaty: ‘I’m pregnant — It can be you or him’

October 31, 2026
McDonald’s dealt legal setback as judge allows lawsuit over McRib’s ‘lack of rib meat’ to proceed
Business

McDonald’s dealt legal setback as judge allows lawsuit over McRib’s ‘lack of rib meat’ to proceed

October 31, 2026
Next Post
Anthony Joshua-Otto Wallin, Deontay Wilder-Joseph Parker boxing live results and analysis

Anthony Joshua-Otto Wallin, Deontay Wilder-Joseph Parker boxing live results and analysis

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Search

No Result
View All Result
AI21 Labs Releases LIFT-Bench to Curb Reward Hacking in RL Training – Unite.AI

AI21 Labs Releases LIFT-Bench to Curb Reward Hacking in RL Training – Unite.AI

October 25, 2026
Current with Christine Romans – Oct. 14 | NBC News NOW

Current with Christine Romans – Oct. 14 | NBC News NOW

October 25, 2026
Apple Creator Studio Update Adds MotionVFX To Final Cut, And AI To Everywhere

Apple Creator Studio Update Adds MotionVFX To Final Cut, And AI To Everywhere

October 27, 2026

About

Learn more

Our Services

Legal

Privacy Policy

Terms of Use

Bloggers

Learn more

Article Links

Contact

Advertise

Ask us anything

©2020- TradePoint.io - All rights reserved!

Tradepoint.io, being just a publishing and technology platform, is not a registered broker-dealer or investment adviser. So we do not provide investment advice. Rather, brokerage services are provided to clients of Tradepoint.io by independent SEC-registered broker-dealers and members of FINRA/SIPC. Every form of investing carries some risk and past performance is not a guarantee of future results. “Tradepoint.io“, “Instant Investing” and “My Trading Tools” are registered trademarks of Apperbuild, LLC.

This website is operated by Apperbuild, LLC. We have no link to any brokerage firm and we do not provide investment advice. Every information and resource we provide is solely for the education of our readers. © 2020 Apperbuild, LLC. All rights reserved.

No Result
View All Result
  • Main
  • AI & Technology
  • Stock Charts
  • Market & News
  • Business
  • Finance Tips
  • Trade Tube
  • Blog
  • Shop

© 2023 - TradePoint.io - All Rights Reserved!